AASTROM BIOSCIENCES INC
10-K, EX-27.1, 2000-09-22
PHARMACEUTICAL PREPARATIONS
Previous: AASTROM BIOSCIENCES INC, 10-K, EX-23.1, 2000-09-22
Next: MRV COMMUNICATIONS INC, 8-K/A, 2000-09-22



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED JUNE 30, 2000, AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                       2,064,000
<SECURITIES>                                10,681,000
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            13,145,000
<PP&E>                                       3,111,000
<DEPRECIATION>                               2,819,000
<TOTAL-ASSETS>                              13,437,000
<CURRENT-LIABILITIES>                        1,002,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    92,367,000
<OTHER-SE>                                (79,932,000)
<TOTAL-LIABILITY-AND-EQUITY>                13,437,000
<SALES>                                              0
<TOTAL-REVENUES>                             1,150,000
<CGS>                                                0
<TOTAL-COSTS>                               10,904,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (9,390,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (9,390,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (9,390,000)
<EPS-BASIC>                                      (.41)
<EPS-DILUTED>                                    (.41)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission